Information Density: Myriad Genetics – Signal Evidence & AI Readability

Myriad Genetics

(https://myriad.com) 📸 Data Snapshot: May 24, 2026
Information Density — The Lens

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Info Density Power-words vs. Substance ratio.
18 Impact Weight: 30 / 100
60% Reputation

The site exhibits a moderate information density where substantive clinical categories (Oncology, Urology, Mental Health) are balanced by high-fluff headings. Power words such as ‘Life Changing,’ ‘Powerful,’ and ‘Illuminating’ appear frequently without immediate quantification; for example, the H2 ‘Powerful tests to illuminate life-changing insights’ contains zero specific nouns or metrics. While the heading hierarchy lists specific medical sub-fields, the lack of immediate technical specifications or data-backed claims in the top-level headers creates a high signal-to-noise ratio.

Information Density is read straight from the body copy: how much of the text carries grounded, checkable substance versus hollow filler. Below is the clean text the engine analyzed, then the industry’s known generic-claim patterns to weigh it against.

📝 The Narrative — clean text per page (the substance-vs-filler signal)
HOMEPAGE · THIN (https://myriad.com) Genetic Testing | Advancing Health with Myriad Genetics

                        
0 chars
SUB-PAGE · THIN (https://myriad.com/genetic-tests/) Genetic Screens & Tests | Myriad Genetics

                        
0 chars
SUB-PAGE · THIN (https://myriad.com/oncology/patients/) Genetic testing for cancer treatment | Patients | Myriad Oncology

                        
0 chars
SUB-PAGE · THIN (https://myriad.com/oncology/providers/) Oncology Genetic Testing | Providers | Myriad Genetics

                        
0 chars
🧭 Industry Context — common generic-claim patterns in Medical Devices, Pharma & Biotech to weigh the text against
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes, pioneering medical science, the future of medicine…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified, patient testimonials making efficacy claims, off-label promotion signals…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations, specific patent numbers and status, pharmacovigilance and adverse event reporting mechanisms…